KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 106 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,593,280 | +26.4% | 91,726 | +2.5% | 0.00% | 0.0% |
| Q2 2023 | $1,260,245 | +18.8% | 89,506 | -9.2% | 0.00% | 0.0% |
| Q1 2023 | $1,060,667 | -5.9% | 98,575 | +31.0% | 0.00% | 0.0% |
| Q4 2022 | $1,127,380 | +15.0% | 75,259 | -1.4% | 0.00% | 0.0% |
| Q3 2022 | $980,000 | +32.6% | 76,312 | +0.1% | 0.00% | – |
| Q2 2022 | $739,000 | -4.3% | 76,228 | -1.8% | 0.00% | – |
| Q1 2022 | $772,000 | -18.4% | 77,658 | -3.4% | 0.00% | – |
| Q4 2021 | $946,000 | +5.0% | 80,367 | +1.6% | 0.00% | – |
| Q3 2021 | $901,000 | -18.8% | 79,112 | -0.7% | 0.00% | -100.0% |
| Q2 2021 | $1,109,000 | -48.2% | 79,655 | -31.1% | 0.00% | 0.0% |
| Q1 2021 | $2,140,000 | +390.8% | 115,635 | +368.1% | 0.00% | – |
| Q4 2020 | $436,000 | +87.1% | 24,704 | +62.0% | 0.00% | – |
| Q3 2020 | $233,000 | -9.3% | 15,252 | +50.8% | 0.00% | – |
| Q2 2020 | $257,000 | +256.9% | 10,116 | +115.6% | 0.00% | – |
| Q1 2020 | $72,000 | +33.3% | 4,691 | -5.7% | 0.00% | – |
| Q4 2019 | $54,000 | +74.2% | 4,973 | +29.1% | 0.00% | – |
| Q3 2019 | $31,000 | -75.6% | 3,852 | -59.7% | 0.00% | – |
| Q2 2019 | $127,000 | -48.4% | 9,559 | -30.6% | 0.00% | – |
| Q1 2019 | $246,000 | +26.2% | 13,764 | +97.2% | 0.00% | – |
| Q4 2018 | $195,000 | -72.3% | 6,981 | -74.8% | 0.00% | – |
| Q3 2018 | $704,000 | – | 27,683 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |